Table 1 miR-655-3p expression and clinicopathological features in hepatocellular carcinoma patients
Characteristics | miR-655-3p expression | p-value | ||
|---|---|---|---|---|
Cases | Low | middle/High | ||
Age (years) | ||||
≥ 53 | 43 | 27(62.8 %) | 16(37.2 %) | 0.69 |
< 53 | 41 | 24(58.5 %) | 17(41.5 %) | |
Gender | ||||
Male | 71 | 45(63.4 %) | 26(36.6 %) | 0.242 |
Female | 13 | 6(46.2 %) | 7(53.8 %) | |
HBsAg status | ||||
Positive | 62 | 36(58.1 %) | 26(41.9 %) | 0.404 |
Negative | 22 | 15(68.2 %) | 7(31.8 %) | |
AFP (ng/ml) | ||||
≥ 20 | 48 | 30(62.5 %) | 18(37.5 %) | 0.699 |
< 20 | 36 | 21(58.3 %) | 15(41.7 %) | |
Liver cirrhosis | ||||
Yes | 63 | 38(60.3 %) | 25(49.7 %) | 0.897 |
No | 21 | 13(61.9 %) | 8(39.1 %) | |
Tumour size (cm) | ||||
< 5 | 44 | 22(50 %) | 22(50 %) | 0.035* |
≥ 5 | 40 | 29(72.5 %) | 11(27.5 %) | |
PVTT | ||||
Yes | 9 | 9(100.0 %) | 0(0.0 %) | 0.028* |
No | 75 | 42(56 %) | 33(44 %) | |
TNM Classification | ||||
I + II | 50 | 24(48 %) | 26(52 %) | 0.004** |
III + IV | 34 | 27(79.4 %) | 7(20.6 %) | |
Tumour differentiation | ||||
Well | 37 | 21(56.8 %) | 16(43.2 %) | 0.721 |
Moderate | 34 | 21(61.8 %) | 13(48.2 %) | |
Poor | 13 | 9(69.2 %) | 4(30.8 %) | |
Metastasis | ||||
Yes | 33 | 27(81.8 %) | 6(18.2 %) | 0.001** |
No | 51 | 24(47.1 %) | 27(52.9 %) | |